Related Experiment Videos
Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application
Abstract:
Cisplatin preferentially accumulates in cells of the S3 segment of the renal proximal tubule and is toxified intracellularly by hydration. The earliest manifestation of toxicity is inhibition of protein synthesis. GSH depletion is another important mechanism causing CP toxicity. Intracellular binding to SH groups leads to GSH depletion, resulting in lipid peroxidation and eventually mitochondrial damage. New measures to prevent GSH depletion and scavenge intracellular free oxygen radicals have been tried in clinical studies. Promising results indicate that cisplatin nephrotoxicity can be further reduced in the future.
Insights
Cisplatin causes kidney damage by accumulating in the S3 segment and depleting glutathione (GSH). Strategies to prevent GSH depletion show promise in reducing cisplatin nephrotoxicity.
Area of Science:
- Nephrology
- Toxicology
- Cell Biology
Background:
- Cisplatin (CP) preferentially accumulates in the S3 segment of the renal proximal tubule.
- Intracellular hydration and subsequent toxification contribute to CP-induced kidney damage.
- Inhibition of protein synthesis is an early indicator of CP toxicity.
Discussion:
- Glutathione (GSH) depletion is a key mechanism in CP nephrotoxicity.
- CP binds to intracellular sulfhydryl (SH) groups, leading to GSH depletion.
- This depletion results in lipid peroxidation and mitochondrial damage.
Key Insights:
- GSH depletion is a critical factor in cisplatin-induced kidney injury.
- Lipid peroxidation and mitochondrial dysfunction are downstream consequences of GSH depletion.
- Targeting GSH levels and free radicals may mitigate CP toxicity.
Outlook:
- Clinical studies are exploring interventions to prevent GSH depletion.
- Scavenging intracellular free oxygen radicals is another therapeutic approach.
- These novel strategies hold promise for reducing cisplatin nephrotoxicity in the future.